Thioctic Acid

DRUG4 trials

Sponsors

The Dana Foundation, National Center for Research Resources (NCRR), MEDA Pharma GmbH & Co. KG

Conditions

Cognitive DisordersDiabetic PolyneuropathyHIV InfectionsMitochondrial Myopathy

Phase 2

A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia

CompletedNCT00002154

The Dana FoundationCognitive Disorders, HIV Infections

Target: 32Updated: 2005-06-24

Phase 3

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)

CompletedNCT00328601

MEDA Pharma GmbH & Co. KGDiabetic Polyneuropathy

Start: 2005-02-28End: 2005-06-30Target: 170Updated: 2022-02-07

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)

CompletedNCT00977483

MEDA Pharma GmbH & Co. KGDiabetic Polyneuropathy

Start: 1998-05-31End: 2005-01-31Updated: 2022-02-07

Unknown Phase

Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy

CompletedNCT00004770

National Center for Research Resources (NCRR)Mitochondrial Myopathy

Start: 1995-10-31Target: 1Updated: 2005-06-24